Completed
Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections
NCT00004276
- Conditions
- Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
Not specified